280 related articles for article (PubMed ID: 6126442)
1. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
[TBL] [Abstract][Full Text] [Related]
2. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
3. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
4. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
5. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
Check JH; Adelson HG; Stern J; Lauer C
Int J Fertil; 1992; 37(2):103-5. PubMed ID: 1349590
[TBL] [Abstract][Full Text] [Related]
6. Comparison of various therapies for the luteinized unruptured follicle syndrome.
Check JH; Dietterich C; Nowroozi K; Wu CH
Int J Fertil; 1992; 37(1):33-40. PubMed ID: 1348733
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy in patients failed to HMG-HCG therapy (author's transl)].
Uemura T; Suzuki N; Kooguchi J; Tsuchihashi S; Shiojima Y
Nihon Funin Gakkai Zasshi; 1976 Jan; 21(1):75-9. PubMed ID: 773720
[No Abstract] [Full Text] [Related]
8. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation.
Jarrell J; McInnes R; Cooke R; Arronet G
Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Muechler EK; Kohler D; Huang KE
Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
12. Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.
Padova G; Briguglia G; Tita P; Arpi ML; Munguira ME; Cafiso F; Cianci A; Ettore G; Pezzino V
Acta Eur Fertil; 1988; 19(5):283-6. PubMed ID: 3150888
[TBL] [Abstract][Full Text] [Related]
13. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
[TBL] [Abstract][Full Text] [Related]
14. Plasma estrogen monitoring of ovulation induction.
Wu CH
Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
[TBL] [Abstract][Full Text] [Related]
15. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
17. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
Schmidt W; von Holst T
Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
Abuzeid MI; Yeoman R; Aksel S
Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
[TBL] [Abstract][Full Text] [Related]
19. Incidence, recurrence and treatment of the luteinized unruptured follicle syndrome.
Temmerman M; Devroey P; Naaktgeboren N; Amy JJ; Van Steirteghem AC
Acta Eur Fertil; 1984; 15(3):179-83. PubMed ID: 6237540
[TBL] [Abstract][Full Text] [Related]
20. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
Ferin J; Thomas K; De Hertogh R
Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
